CHC Group Ltd, dELiA*s, Inc. Climb Midday

CHC Group Ltd, dELiA*s, Inc. Climb Midday

CHC Group Ltd (NYSE:HELI), dELiA*s, Inc. (NASDAQ:DLIA) and Repros Therapeutics Inc (NASDAQ:RPRX) are today’s top midday gainers. Ending the week on a sour note are this Friday’s midday losers – Inc (ADR) (NYSE:WUBA), Flexion Therapeutics Inc (NASDAQ:FLXN) and Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR).

CHC Group Climbs on Investment News

CHC Group Ltd (NYSE:HELI) surged +12.12% today following news that Clayton Dubilier & Rice has agreed to invest $500 million in the company. The commercial helicopter operator and Farallon Capital holding is down -29.18% year-to-date.

Alluvial Fund May 2021 Performance Update

Alluvial FundAlluvial Fund performance update for the month ended May 2021. Q1 2021 hedge fund letters, conferences and more Dear Partners and Colleagues, Alluvial Fund, LP returned 5.4% in May, compared to 0.2% for the Russell 2000 and 1.0% for the MSCI World Small+MicroCap . . . SORRY! This content is exclusively for paying members. SIGN UP Read More

The share price of dELiA*s, Inc. (NASDAQ:DLIA) hit midday up +11.43% this Friday, though its price is still down -47.31% YTD. Tiger Global purchased 3.4 million DLIA assets during the fourth quarter of 2013 and has maintained the position during the first and second quarters of 2014.

Repros Therapeutics Inc (NASDAQ:RPRX) climbed +9.79% today, continuing on a positive trend in recent weeks. It reported a second quarter loss of 38 cents per share earlier this month but is still up +13.6% over the past five days. Farallon Capital has held a position in the company since the first quarter of last year. Slides on Lowered Expectations

The share price of Inc (ADR) (NYSE:WUBA) fell -4.94% today. The China-based online marketplace reported better-than-expected Q2 results yesterday but lowered its guidance for Q3. As of the second quarter of this year, Tiger Global holds 1.26 million WUBA assets.

George Soros pick Flexion Therapeutics Inc (NASDAQ:FLXN) dipped -3.81% today, putting its year-to-date loss at -11.62%. The specialty pharmaceutical company reported second quarter results earlier this month, including a net loss of $5.9 million. Despite today’s dip, its price has climbed +4.5% in the past month.

Taking the third and final spot on today’s list of midday losers is Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), down -3.12%. In the investment portfolio of billionaire investor Ray Dalio since the first quarter of 2013, PBR is up +23.95% year-to-date and +49.43% over the past six months.

No posts to display